Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study. Infectious Diseases and Therapy, 9(1): 41-52. In by AHFNovember 15, 2019 Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Chronic Kidney Disease Risk Score in HIV-Infected Patients in the USA. HIV Medicine, 21: 299-308. Benchmarking HIV Quality Measures in the US OPERA HIV Cohort. Open Forum Infectious Diseases, 6(10): 1-9. Download File Type: pdf File Size: 250 KB Categories: 2019 Tags: 2015-2019
